spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairley, E. A. L.
Right arrow Articles by Kendrick-Jones, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairley, E. A. L.
Right arrow Articles by Kendrick-Jones, J.
Journal of Cell Science 115, 341-354 (2002)
© 2002 The Company of Biologists Limited


Research Article

The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype

Elizabeth A. L. Fairley1,*, Andrew Riddell2, Juliet A. Ellis2,{ddagger} and John Kendrick-Jones1

1 MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK
2 Wellcome Trust Centre for the Molecular Mechanism in Disease, Addenbrooke’s Hospital, Cambridge, CB2 2XY, UK
{ddagger} Present address: Randall Centre for the Molecular Mechanism of Cell Function, Kings College, New Hunts House, Guy’s Campus, London, SE1 1UL, UK

*Author for correspondence (e-mail: ealf{at}mrc-lmb.cam.ac.uk)

Accepted October 24, 2001

Emerin is the nuclear membrane protein defective in X-linked Emery-Dreifuss muscular dystrophy (X-EDMD). The majority of X-EDMD patients have no detectable emerin. However, there are cases that produce mutant forms of emerin, which can be used to study its function. Our previous studies have shown that the emerin mutants S54F, P183T, P183H, Del95-99, Del236-241 (identified in X-EDMD patients) are targeted to the nuclear membrane but to a lesser extent than wild-type emerin. In this paper, we have studied how the mislocalisation of these mutant emerins may affect nuclear functions associated with the cell cycle using flow cytometry and immunofluorescence microscopy. We have established that cells expressing the emerin mutant Del236-241 (a deletion in the transmembrane domain), which was mainly localised in the cytoplasm, exhibited an aberrant cell cycle length. Thereafter, by examining the intracellular localisation of endogenously expressed lamin A/C and exogenously expressed wild-type and mutant forms of emerin after a number of cell divisions, we determined that the mutant forms of emerin redistributed endogenous lamin A/C. The extent of lamin A/C redistribution correlated with the amount of EGFP-emerin that was mislocalised. The amount of EGFP-emerin mislocalized, in turn, was associated with alterations in the nuclear envelope morphology. The nuclear morphology and redistribution of lamin A/C was most severely affected in the cells expressing the emerin mutant Del236-241.

It is believed that emerin is part of a novel nuclear protein complex consisting of the barrier-to-autointegration factor (BAF), the nuclear lamina, nuclear actin and other associated proteins. The data presented here show that lamin A/C localisation is dominantly directed by its interaction with certain emerin mutants and perhaps wild-type emerin as well. These results suggest that emerin links A-type lamins to the nuclear envelope and that the correct localisation of these nuclear proteins is important for maintaining cell cycle timing.

Key words: Emerin, Lamin A/C, Cell cycle, Protein targeting, Emery-Dreifuss muscular dystrophy




This article has been cited by other articles:


Home page
BrainHome page
F. Muntoni, G. Bonne, L. G. Goldfarb, E. Mercuri, R. J. Piercy, M. Burke, R. B. Yaou, P. Richard, D. Recan, A. Shatunov, et al.
Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins
Brain, May 1, 2006; 129(5): 1260 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J. Lammerding, J. Hsiao, P. C. Schulze, S. Kozlov, C. L. Stewart, and R. T. Lee
Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells
J. Cell Biol., August 29, 2005; 170(5): 781 - 791.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Tulac, C. Dosiou, E. Suchanek, and L. C. Giudice
Silencing lamin A/C in human endometrial stromal cells: a model to investigate endometrial gene function and regulation
Mol. Hum. Reprod., October 1, 2004; 10(10): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. S. Masny, U. Bengtsson, S.-A. Chung, J. H. Martin, B. van Engelen, S. M. van der Maarel, and S. T. Winokur
Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
Hum. Mol. Genet., September 1, 2004; 13(17): 1857 - 1871.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2002